CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net earnings	$ 185,325	$ 190,580
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization	83,520	86,240
Loss on divestiture	4,651	0
Impairment of assets held for sale	0	8,656
Gain on sale/disposal of long-lived assets	(4,241)	(604)
Deferred income taxes	5,759	4,480
Share-based compensation	12,027	10,861
Change in operating assets and liabilities, net of businesses acquired and divested:
Accounts receivable, net	(70,548)	(81,498)
Inventories, net	(89,318)	(5,045)
Progress Payments	(1,330)	(3,960)
Accounts payable and accrued expenses	(42,360)	(51,702)
Deferred revenue	(39,230)	115
Net pension and postretirement liabilities	(3,913)	2,406
Other current and long-term assets and liabilities	(37,955)	(4,768)
Net cash provided by operating activities	2,387	155,761
Cash flows from investing activities:
Proceeds from sale/disposal of long-lived assets	9,110	3,389
Purchases of investments	(10,000)	0
Additions to property, plant, and equipment	(28,789)	(27,858)
Acquisition of business, net of cash acquired	(247,215)	0
Additional consideration paid on prior year acquisitions	5,062	5,340
Net cash used for investing activities	(281,956)	(29,809)
Cash flows from financing activities:
Borrowings under revolving credit facility	1,332,219	166,771
Payments of revolving credit facilities	(1,038,019)	(166,771)
Repurchases of common stock	(44,434)	(79,092)
Proceeds from share-based compensation	9,997	9,705
Dividends paid	(14,220)	(14,320)
Proceeds from (Payments for) Other Financing Activities	(755)	(699)
Net cash (used for)/provided by financing activities	244,788	(84,406)
Effect of exchange-rate changes on cash	(22,671)	(5,378)
Net increase (decrease) in cash and cash equivalents	(57,452)	36,168
Cash and cash equivalents at beginning of period		198,248
Cash and cash equivalents at end of period	$ 113,552	$ 234,416